Results

Total Results: 579 records

Showing results for "Grade D Cancer".

21. Evidence-based Practice Center Review Protocol (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/pdf/prostate-cancer-surveillance_research-protocol.pdf
    May 19, 2011 - The cancer is often localized, and most tumors have low histological grades and Gleason Scores. … Tumor Characteristics i. Stage ii. Tumor volume iii. Gleason Score iv. PSA c. … In addition to prostate neoplasms/cancer, search terms will include “active surveillance,” “watchful … D. … Owens DK, Lohr KN, Atkins D, et al.

22. Local Therapies for Unresectable Colorectal Cancer Metastases to the Liver: A Comparative Effectiveness Review | Effective Health Care (EHC) Program
    effectivehealthcare.ahrq.gov/products/colorectal-cancer-liver-metastases-therapies/research-protocol
    January 31, 2012 - die with hepatic metastases. 1 Colorectal cancer is the most common malignancy that metastasizes to … "[Mesh] OR ((hepatic OR liver) AND (cancer OR cancers OR oncology OR neoplasms)) AND "Colorectal Neoplasms … OR cancers OR oncology OR neoplasms AND colon OR colorectal OR rectal OR intestinal OR rectum OR intestine … D. … Is Extended Hepatectomy for Hepatobiliary Malignancy Justified? Ann Surg 2004;239(5):722-32.

23. Treatment of Stages I-III Squamous Cell Anal Cancer: A Systematic Review (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/related_files/anal-cancer-draft-report.pdf
    October 31, 2023 - proton beam radiotherapy, and de-escalation of radiation dosing for appropriate stages.6 More advanced tumors … myelosuppression, gastrointestinal toxicity, such as diarrhea, vomiting, and bowel obstruction, secondary malignancy … , and tumor histologic grade and size not reported. … Insufficient Tumor related colostomy-free survival 1; NRSI; n=779 Favors IMRT Insufficient Acute grade … Eur J Cancer. 2009;45(1):2782-2791. 33. Goodman KA, Julie D, Cercek A, et al.

24. Comparative Effectiveness of Epoetin and Darbepoetin for Managing Anemia in Patients Undergoing Cancer Treatment–An Update to the 2006 Report | Effective Health Care (EHC) Program
    effectivehealthcare.ahrq.gov/products/cancer-anemia-update/research-protocol
    June 16, 2010 - The prevalence of anemia varies according to the type of neoplasia. 7 Patients with hematological malignancies … D. … versus hematological malignancies versus mixed (studies including both solid tumors and hematological … Cancer 1994;73(10): 2535-42. Cella D. … AND ("Neoplasms"[Mesh] OR "Carcinoma"[Mesh] OR malignan* OR cancer OR cancers OR cancerous OR oncolog

25. NIH State-of-the-Science Conference: Role of Active Surveillance in the Management of Men With Localized Prostate Cancer | Effective Health Care (EHC) Program
    effectivehealthcare.ahrq.gov/products/prostate-cancer-surveillance/research-protocol
    May 19, 2011 - The cancer is often localized, and most tumors have low histological grades and Gleason Scores. … Patient Characteristics Age Comorbidity Race/ethnicity Tumor Characteristics Stage Tumor volume … In addition to prostate neoplasms/cancer, search terms will include “active surveillance,” “watchful … D. … Owens DK, Lohr KN, Atkins D, et al.

26. Evidence-based Practice Center Systematic Review Protocol (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/pdf/colorectal-cancer-screening_research-protocol.pdf
    May 18, 2011 - For advanced neoplasia. … D. … (16) Chou R, Aronson N, Atkins D et al. … (17) Owens DK, Lohr KN, Atkins D et al. … Colonic Polyps/ 14 Colonic Neoplasms/ 15 Sigmoid Neoplasms/ 16 Rectal Neoplasms/ 17 Anus Neoplasms

27. Comparative Effectiveness of Therapies for Clinically Localized Prostate Cancer: An Update of a 2008 Comparative Effectiveness Review | Effective Health Care (EHC) Program
    effectivehealthcare.ahrq.gov/products/prostate-cancer-therapies-update/research-protocol
    March 29, 2013 - healthy men of all ages, concluding that the harms of screening outweigh the benefits (Grade D recommendation … tumor grade in terms of the Gleason score, which ranges from 2 to 10. 4 Gleason 8–10 tumors are considered … EMTREE) Neoplasms/ Prostate/ Prostatic Neoplasms/ Cancer* Carcinoma* Neoplasm* … Neoplasms/ or neoplasm$ or carcinoma$) 3 Combine sets S1 OR S2 4 Treatment options watchful … /radiotherapy”[mesh] 2 Prostate cancer “prostatic neoplasms”[mesh] OR (prostat*[tiab] AND (neoplasm

28. Prostate-Cancer-Test Research-Protocol (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/pdf/prostate-cancer-test_research-protocol.pdf
    October 14, 2011 - Indolent Cancers of the Prostate (Key Question 3) Figure 2. … ] (OR text words “prostate cancer”, “prostatic cancer”, “prostate neoplasms”, “prostatic neoplasms” … D. … Moher D, Pham B, Klassen TP, et al. … "[Mesh] OR "prostatic neoplasms" OR "prostate neoplasms" OR "prostatic cancer" OR "prostate cancer"

29. Prostate-Cancer-Test Executive (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/related_files/prostate-cancer-test_executive.pdf
    April 01, 2013 - leading cause of cancer deaths in men in the United States.1,2 Most patients have slow-growing tumors … outcomes was evaluated using the Grading of Recommendations Assessment, Development and Evaluation (GRADE … ) system.21 GRADE addresses four domains of evidence (risk of bias, consistency, directness, and precision … PCA3 score before radical prostatectomy predicts extracapsular extension and tumor volume. … PCA3 molecular urine assay correlates with prostate cancer tumor volume: implication in selecting candidates

30. A Primary Care-Focused, Computer-based Clinical Decision Support Tool to Assess Patients’ Risk for Deleterious BRCA Mutations | Effective Health Care (EHC) Program
    effectivehealthcare.ahrq.gov/products/breast-cancer-genetic-tests/research
    December 02, 2010 - susceptibility gene 1 (BRCA1) or breast cancer susceptibility gene 2 (BRCA2). … Grade: D Recommendation. … Grade: B Recommendation. … Women who have a mutation in these genes have up to an 85 percent lifetime risk of breast cancer. … The tumors of BRCA1 mutation carriers are more likely to be high-grade, estrogen-receptor negative and

31. Evidence-based Practice Center Systematic Review Protocol (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/pdf/cancer-anemia-update_research-protocol.pdf
    June 16, 2010 - The prevalence of anemia varies according to the type of neoplasia.7 Patients with hematological malignancies … versus hematological malignancies versus mixed (studies including both solid tumors and hematological … Cancer 1994;73(10): 2535-42. 14. Cella D. … * OR tumor OR tumors OR tumour* OR neoplas* OR carcinom* #59 Search erythropoietin OR epoetin* OR … * OR tumor OR tumors OR tumour* OR neoplas* OR carcinom*) AND ("adverse effects "[Subheading

32. Menopause-Protocol-130612 (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/related_files/menopause-protocol-130612.pdf
    June 12, 2013 - Lunn D, Spiegelhalter D, Thomas A, et al. … “Colorectal Neoplasms” (mh) OR ((colorectal OR colon) AND (neoplasm* OR cancer OR carcinoma)) AND … OR ((ovarian OR breast OR colorectal OR colon OR endometrial) AND (cancer OR cancers OR carcinoma OR … #59 ‘colorectal neoplasms’/exp OR (colorectal OR ‘colon’/exp OR intestinal AND (‘neoplasm’/exp OR … /lim #60 #17 AND #59 #61 #56 AND #60 Ovarian Cancer #61 ‘ovarian’/exp AND (‘neoplasm’/exp OR

33. PCA3 Testing for the Diagnosis and Management of Prostate Cancer | Effective Health Care (EHC) Program
    effectivehealthcare.ahrq.gov/products/prostate-cancer-test/research-protocol
    October 14, 2011 - Indolent Cancers of the Prostate (Key Question 3) Figure 2. Analytic framework for KQ 3. … OR text words “prostate cancer”, “prostatic cancer”, “prostate neoplasms”, “prostatic neoplasms”) AND … D. … Moher D, Pham B, Klassen TP, et al. … "[Mesh] OR "prostatic neoplasms" OR "prostate neoplasms" OR "prostatic cancer" OR "prostate cancer"

34. Local Therapies for the Treatment of Stage I Non-Small Cell Lung Cancer and Endobronchial Obstruction Due to Advanced Lung Tumors | Effective Health Care (EHC) Program
    effectivehealthcare.ahrq.gov/products/lung-cancer-nonsurgical-therapies/research-protocol
    February 22, 2012 - recurrence, noncancer-related mortality, and second malignancies. 2, 3 Malignant Endobronchial Obstruction … D. … Owens DK, Lohr KN, Atkins D, et al. … '/exp OR ('lung neoplasms'/exp OR 'lung cancer'/exp AND ('non-small-cell' OR 'non-small cell' OR 'non … '/exp OR ('lung neoplasms'/exp OR 'lung cancer'/exp AND ('non-small-cell' OR 'non-small cell' OR 'non

35. Menopausal Symptoms: Comparative Effectiveness Review of Therapies | Effective Health Care (EHC) Program
    effectivehealthcare.ahrq.gov/products/menopause/research-protocol
    April 03, 2012 - D. … “Colorectal Neoplasms” (mh) OR ((colorectal OR colon) AND (neoplasm* OR cancer OR carcinoma)) AND ( … OR ((ovarian OR breast OR colorectal OR colon OR endometrial) AND (cancer OR cancers OR carcinoma OR … #59 ‘colorectal neoplasms’/exp OR (colorectal OR ‘colon’/exp OR intestinal AND (‘neoplasm’/exp OR ‘ … #60 #17 AND #59 #61 #56 AND #60 Ovarian Cancer #61 ‘ovarian’/exp AND (‘neoplasm’/exp OR ‘neoplasms

36. Diagnosis and Treatment of Non-muscle Invasive Bladder Cancer | Effective Health Care (EHC) Program
    effectivehealthcare.ahrq.gov/get-involved/nominated-topics/diagnosis-and-treatment-of-non-muscle-invasive-bladder-cancer
    October 03, 2012 - How do tumor characteristics (stage, grade, multiplicity, size, molecular and genetic alterations) predict … Genetic and epidemiological evidence indicates that African Americans may have a more aggressive form of malignancy … Yee D, Ishill M, Lowrance W et al: Ethnic differences in bladder cancer survival. … for 90% of all malignant tumors. … tumors that are papillary in nature and limited to the mucosa (Ta), high-grade and flat and confined

37. Management of Renal Masses and Localized Renal Cell Carcinoma: Current State of the Evidence | Effective Health Care (EHC) Program
    effectivehealthcare.ahrq.gov/products/renal-cancer/clinician
    July 18, 2017 - Renal cell carcinoma accounts for more than 94 percent of kidney malignancies. … Tumor size and male sex are the factors that are statistically significantly associated with malignancy … The Clavien-Dindo classification system is used to grade complications from urological surgical interventions … : Dindo D, Demartines N, Clavien PA. … Tumor Size 12 (9,401) A positive relationship between tumor size and malignancy risk was found.

38. CER 174 Executive Summary: Imaging for the Pretreatment of Small Cell Lung Cancer (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/lung-cancer-staging_executive.pdf
    April 01, 2016 - percent of all lung cancers.3 Despite advances in diagnosis, treatment, and management of lung … Lung cancers are classified based on the size of the main tumor, whether it has locally invaded other … anatomic sites that harbor metabolically active malignant areas, FDG-PET helps distinguish malignant tumors … Tumor response d. Harms due to overtreatment or undertreatment e. Survival f. … the clinical staging of small cell lung cancer in the forthcoming (seventh) edition of the tumor, node

39. Template for Reports Developed (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/pdf/menopause_research-protocol.pdf
    March 25, 2012 - D. … “Colorectal Neoplasms” (mh) OR ((colorectal OR colon) AND (neoplasm* OR cancer OR carcinoma)) AND … OR ((ovarian OR breast OR colorectal OR colon OR endometrial) AND (cancer OR cancers OR carcinoma OR … #59 ‘colorectal neoplasms’/exp OR (colorectal OR ‘colon’/exp OR intestinal AND (‘neoplasm’/exp OR … /lim #60 #17 AND #59 #61 #56 AND #60 Ovarian Cancer #61 ‘ovarian’/exp AND (‘neoplasm’/exp OR

40. 04-E029-1 Summary (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/related_files/prostate-cancer-surveillance_executive.pdf
    December 01, 2011 - Tumor grade Five studies (covering 1973–2005) reported prostate cancer incidence rates stratified by … tumor grade (level of tumor differentiation or Gleason score). … Tumor grade Three studies reported information on prostate cancer mortality stratified by tumor grade … One required that less than 25 percent of the tumor was Gleason grade 4 and less than 5 percent grade … grade (≥7) tumors, and a concomitant increase in intermediate grade tumors (Gleason 5–6).